Drug Trial Radar · NCT03974022
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)
Last checked: Nov 20, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
315
Actual
Start
Jul 9, 2019
Primary completion
Jul 29, 2024
Study completion Dec 2026
Sponsor
- Lead sponsor
- Dizal PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jun 4, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will treat patients with advanced NSCLC with EGFR or HER2 mutation who have progressed following prior therapy. This is the first time this drug is tested in patients, and so it will help to understand what type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer activity as monotherapy.
Conditions
- Non-Small Cell Lung Cancer
Interventions
SunvozertinibDrug
Daily dose of Sunvozertinib
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A Dose Escalation: Dose Limiting Toxicities (DLTs).Time frame: The DLT observation period is defined as the 28 days after the first multiple dose (up to 36 days from baseline).
- Part B: Objective Response Rate (ORR) According to RECIST 1.1 by an Independent Review Committee (IRC).Time frame: through the study completion, an average of around 1 year for part B
Locations
124 sites in 13 countries. Site status is shown where the registry gives one.
University of California, San Diego (UCSD) - Moores Cancer Center
La Jolla, California
University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center
Orange, California
Innovative Clinical Research Institute, LLC
Whittier, California
University of Colorado Hospital - Anschutz Cancer Pavilion
Aurora, Colorado
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
Dana-Farber Cancer Institute
Boston, Massachusetts
Michigan Center of Medical Research
Farmington Hills, Michigan
Northwell Health - Centers for Advanced Medicine
New Hyde Park, New York
Laura and Isaac Perlmutter Cancer Center
New York, New York
Icahn School of Medicine at Mount Sinai
New York, New York
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Virginia Cancer Specialists
Fairfax, Virginia
Fundacion Respirar - Consultorios Medicos Dr. Doreski
Cabildo, Argentina
CEMIC Centro de Educación Médica e Investigaciones Clínicas - Hospital Universitario sede Saavedra
Ciudad Autónoma Buenos Aires, Argentina
Centro Medico Austral OMI
Ciudad Autónoma Buenos Aires, Argentina
Diabaid
Ciudad Autónoma Buenos Aires, Argentina
Fundacion CENIT Para La Investigacion en Neurociencias
Ciudad Autónoma Buenos Aires, Argentina
Instituto Argentino de Diagnositco y Tratamiento S.A.
Ciudad Autónoma Buenos Aires, Argentina
Instituto Medico de la Fundacion de Estudios Clínicos
Ciudad Autónoma Buenos Aires, Argentina
Centro de Investigación Pergamino SA
Pergamino, Argentina
Clinica Viedma S.A
Viedma, Argentina
Blacktown Hospital
Blacktown, Australia
Chris O'Brien Lifehouse
Camperdown, Australia
Austin Hospital
Heidelberg, Australia
St George Hospital
Kogarah, Australia
Peter MacCallum Cancer Centre - East Melbourne
North Melbourne, Australia
Linear Cancer trials
Perth, Australia
Southern Medical Day Care Centre
Wollongong, Australia
Princess Margaret Cancer Centre
Toronto, Canada
Fundación Arturo López Pérez
Providencia, Chile
Orlandi Oncología - Centro Médico Health & Care
Santiago, Chile
SAGA
Santiago, Chile
James Lind Centro De Investigacion Del Cancer
Temuco, Chile
Beijing Cancer Hospital
Beijing, China
Beijing Chest Hospital,Capital Medical University
Beijing, China
Peking Union Medical College Hospital
Beijing, China
Jilin Cancer Hospital
Changchun, China
Hunan Cancer Hospital
Changsha, China
West China Hospital of Sichuan University
Chengdu, China
Chongqing Cancer Hospital
Chongqing, China
Showing 40 of 124 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.